Children’s Health

Metafora biosystems receives €3.2 million from European Commission’s H2020 SME Instrument program

June 11, 2018

Metafora biosystems receives €3.2 million from European Commission’s H2020 SME Instrument program Grant will allow company to launch large-scale prospective validation study of METAglut1 test to help early diagnosis of rare De Vivo disease (Glut1 deficiency syndrome) Paris, France – June 11, 2018 – Metafora biosystems, a company developing diagnostic tests to detect abnormalities in […]

New study launched to identify women at high risk of preterm birth, most effective interventions

June 6, 2018

Researchers are launching the first study of its kind involving up to 10,000 women that will use a new test to identify those at risk for premature birth, and, in those with high risk, to evaluate the impact of early interventions designed to prolong their pregnancy and reduce the rate of premature delivery. For the […]

Metafora biosystems receives exceptional reimbursement for new blood test to help diagnose De Vivo disease

April 16, 2018

METAglut1 test enables early detection of this rare under-diagnosed disease A 30-month long study will be carried out on 3,000 patients in 60 centers across France Paris, France, April 11, 2018 – Metafora biosystems, a company developing diagnostic tests to detect abnormalities in cellular energetics, today announces it has been granted ‘Forfait Innovation’ funding for […]

International Conference on Diabetes and Healthcare

April 3, 2018

Meeting International would like to invite you to the “International Conference on Diabetes and Healthcare” during June 25-06-2018 to 27-06-2018 at Toronto, Canada. This conference is focusing on the theme “Transmitting latest Innovations & Applications in the field of Diabetes”.  For more details of the conference please have a glance on webpage: http://www.meetingsint.com/conferences/diabetes-healthcare

FEEDBACK